Some aspects of plaque formation by human influenza viruses. II. Viral factors influencing plaque production.
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology; D002460:Cell Line; D002642:Chick Embryo; D003470:Culture Media; D046508:Culture Techniques; D003588:Cytopathogenic Effect, Viral; D004352:Drug Resistance, Microbial; D005347:Fibroblasts; D000882:Haplorhini; D006385:Hemagglutination Inhibition Tests; D006386:Hemagglutination Tests; D006736:Horses; D006801:Humans; D007106:Immune Sera; D007668:Kidney; D008168:Lung; D051379:Mice; D009975:Orthomyxoviridae / Q000187:drug effects / Q000254:growth & development* / Q000276:immunology / Q000472:pathogenicity; D011134:Polysaccharides; D013045:Species Specificity; D013997:Time Factors; D014776:Virus Cultivation
D000998:Antiviral Agents; D003470:Culture Media; D007106:Immune Sera; D011134:Polysaccharides